| Autor: |
Heijden, Lizz, Dijkstra, P.D. Sander, Sande, Michiel A.J., Kroep, Judith R., Nout, Remi A., Rijswijk, Carla S.P., Bovée, Judith V.M.G., Hogendoorn, Pancras C.W., Gelderblom, Hans |
| Předmět: |
|
| Zdroj: |
Oncologist; Nov2014, Vol. 19 Issue 11, p1027-1208, 3p |
| Abstrakt: |
The authors respond to the observations and remarks of Cavanna et al. concerning the clinical guidance paper on giant cell tumor of bone (GCTB) in the era of denosumab and update the paper with respect to the European Medicines Agency's recent positive opinion recommending denosumab for the treatment of adults and skeletally mature adolescents with GCTB that is unresectable or for which surgical resection is likely to result in severe morbidity [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text